The latest update on Sears, recent research from Hodes Weill and Cornell University showing a rise in target allocations. David also shares news from the Boston area on the life sciences market, and whether it is it signalling a downturn ahead.
With moderate new construction and steady job growth, investors are willing to tolerate the risk of value-add strategies.